A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data.
Morita S, Oka Y, Tsuboi A, Kawakami M, Maruno M, Izumoto S, Osaki T, Taguchi T, Ueda T, Myoui A, Nishida S, Shirakata T, Ohno S, Oji Y, Aozasa K, Hatazawa J, Udaka K, Yoshikawa H, Yoshimine T, Noguchi S, Kawase I, Nakatsuka S, Sugiyama H, Sakamoto J.
Morita S, et al. Among authors: sakamoto j.
Jpn J Clin Oncol. 2006 Apr;36(4):231-6. doi: 10.1093/jjco/hyl005. Epub 2006 Apr 12.
Jpn J Clin Oncol. 2006.
PMID: 16611662
Clinical Trial.